Chanda PK - Search Results

1

Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase.

Moy FJ, Pisano MR, Chanda PK, Urbano C, Killar LM, Sung ML, Powers R. Moy FJ, et al. Among authors: chanda pk. J Biomol NMR. 1997 Jul;10(1):9-19. doi: 10.1023/a:1018362914316. J Biomol NMR. 1997. PMID: 9335112

2

High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.

Moy FJ, Chanda PK, Cosmi S, Pisano MR, Urbano C, Wilhelm J, Powers R. Moy FJ, et al. Among authors: chanda pk. Biochemistry. 1998 Feb 10;37(6):1495-504. doi: 10.1021/bi972181w. Biochemistry. 1998. PMID: 9484219

3

NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.

Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Skotnicki JS, Wilhelm J, Powers R. Moy FJ, et al. Among authors: chanda pk. Biochemistry. 1999 Jun 1;38(22):7085-96. doi: 10.1021/bi982576v. Biochemistry. 1999. PMID: 10353819

4

Letter to the editor: 1H, 15N, 13C, and 13CO assignments and secondary structure determination of collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.

Moy FJ, Chanda PK, Cosmi S, Edris W, Levin JI, Powers R. Moy FJ, et al. Among authors: chanda pk. J Biomol NMR. 2000 Jul;17(3):269-70. doi: 10.1023/a:1008305025043. J Biomol NMR. 2000. PMID: 10959634 No abstract available.

5

High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.

Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R. Moy FJ, et al. Among authors: chanda pk. J Mol Biol. 2000 Sep 22;302(3):671-89. doi: 10.1006/jmbi.2000.4082. J Mol Biol. 2000. PMID: 10986126

6

Impact of mobility on structure-based drug design for the MMPs.

Moy FJ, Chanda PK, Chen J, Cosmi S, Edris W, Levin JI, Rush TS, Wilhelm J, Powers R. Moy FJ, et al. Among authors: chanda pk. J Am Chem Soc. 2002 Oct 30;124(43):12658-9. doi: 10.1021/ja027391x. J Am Chem Soc. 2002. PMID: 12392402

7

1H, 15N, 13C, and 13CO assignments and secondary structure determination of RGS4.

Moy FJ, Chanda PK, Cockett MI, Edris W, Jones PG, Powers R. Moy FJ, et al. Among authors: chanda pk. J Biomol NMR. 1999 Dec;15(4):339-40. doi: 10.1023/a:1008343609739. J Biomol NMR. 1999. PMID: 10685342 No abstract available.

8

NMR structure of free RGS4 reveals an induced conformational change upon binding Galpha.

Moy FJ, Chanda PK, Cockett MI, Edris W, Jones PG, Mason K, Semus S, Powers R. Moy FJ, et al. Among authors: chanda pk. Biochemistry. 2000 Jun 20;39(24):7063-73. doi: 10.1021/bi992760w. Biochemistry. 2000. PMID: 10852703

9

Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.

Levin JI, Gu Y, Nelson FC, Zask A, DiJoseph JF, Sharr MA, Sung A, Jin G, Cowling R, Chanda P, Cosmi S, Hsiao CL, Edris W, Wilhelm J, Killar LM, Skotnicki JS. Levin JI, et al. Bioorg Med Chem Lett. 2001 Jan 22;11(2):239-42. doi: 10.1016/s0960-894x(00)00644-2. Bioorg Med Chem Lett. 2001. PMID: 11206468

10

Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.

Chanda PK, Minchin MC, Davis AR, Greenberg L, Reilly Y, McGregor WH, Bhat R, Lubeck MD, Mizutani S, Hung PP. Chanda PK, et al. Mol Pharmacol. 1993 Apr;43(4):516-20. Mol Pharmacol. 1993. PMID: 8474430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters